News

Health on MSN9h
Zepbound or Wegovy? Head-to-Head Trial Says One Is Better for Weight Loss
Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...
WBAL-TV2h
Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...
Zacks Investment Research on MSN13h
3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies
The obesity market has garnered much interest lately, propelled by the success of GLP-1 therapies Wegovy and Zepbound, marketed by pharma giants Novo Nordisk NVO and Eli Lilly LLY, respectively. This ...
STAT16h
New budget bans Medicaid coverage of trans gender-affirming care
How a new Trump plan could make science ‘a political football’ The NIH is already in turmoil. Billlions of dol ...
Wolfspeed bankruptcy path splits creditors, angers Reddit, and shapes NC factory
Plus, peek inside Raleigh’s newest data center, a Duke researcher reflects on her canceled federal grant amid buyouts, and ...